Evidence map›Paper›PMID 42078389›Full record

ArticlemedRxiv : the preprint server for health sciences2026

Do Amyloid Trajectories Reach a Physiologic Ceiling? Evidence from Iterative Approximation and Simulation.

Jason R Gantenberg, Renaud La Joie, Margo B Heston, Sarah F Ackley, Alzheimer’s Disease Neuroimaging Initiative

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Jason R GantenbergDepartment of Health Services, Policy, and Practice, Brown University, 121 S. Main St., Providence, RI 02903.ORCID 0000-0002-8144-4273
Renaud La JoieEdward and Pearl Fein Memory and Aging Center, Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, 1651 4th St Suite 212, San Francisco, CA 94158.ORCID 0000-0003-2581-8100
Margo B HestonEdward and Pearl Fein Memory and Aging Center, Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, 1651 4th St Suite 212, San Francisco, CA 94158.ORCID 0000-0002-0980-2275
Sarah F AckleyDepartment of Epidemiology, Brown University, 121 S. Main St., Providence, RI 02903.ORCID 0000-0003-0181-6063
Alzheimer’s Disease Neuroimaging Initiative

Funding

Research Education ComponentP30AG062422 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Katherine P Rankin · 2019 to 2026
$36.9M
Mathematical Models of Tau-PET Measures and Cognitive Decline in Alzheimer's Disease Across the LifespanR00AG073454 · NIA · BROWN UNIVERSITY · PI Sarah Ackley · 2024 to 2026
$742k
The Disadvantage Exposome as a Driver of Alzheimer’s Disease PathologyK00AG097172 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Margo Heston · 2025 to 2026
$169k
NIA NIH HHS K00 AG097172NIA NIH HHS P30 AG062422NIA NIH HHS R00 AG073454
6 · The paper itself

Abstract

Qualitative models of Alzheimer's pathology often posit that amyloid accumulation follows a sigmoid curve, indicating that the rate of deposition wanes over time. Longitudinal PET data now allow us to investigate amyloid accumulation trajectories with greater detail and over longer follow-up periods. We combine inferences from simulated amyloid trajectories, empirical PET data from the Alzheimer's Disease Neuroimaging Initiative (ADNI), and the sampled iterative local approximation algorithm (SILA) to assess whether amyloid accumulation reaches a physiologic ceiling. We find that SILA reliably detects a ceiling, when present, across a range of simulated scenarios that impose a sigmoid shape. When fit to empirical data from ADNI, however, SILA does not appear to indicate the presence of a ceiling. Thus, we conclude that amyloid trajectories may not reach a physiologic ceiling during the stages of Alzheimer's disease typically observed while patients remain under follow-up in cohort studies. Fits using SILA indicate that illustrative models of biomarker cascades, while useful tools for conceptualizing and interrogating pathologic processes, may not represent the shapes of amyloid trajectories accurately.

Identifiers

PMID42078389
PMCPMC13131744

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.